Cargando…
Hypercoagulopathy as a severe Long-term complication of post SARS-CoV-19 infection
Two years since the advent of the COVID-19 pandemic, it is time to discuss the long-term complications post virus infection. We are reporting three autopsy cases from patients who had COVID-19 one to six months before death. All three patients were SARS-CoV-2 negative at admission but expired shortl...
Autores principales: | Zhang, Xinhai R., Agarwal, Indu, Jing, Jian, Cheng, Lin, Scaria, Gladson, Latef, Mamoor, Gattuso, Paolo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Author(s). Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8810306/ http://dx.doi.org/10.1016/j.hpr.2022.300595 |
Ejemplares similares
-
Value of thromboelastography in managing hypercoagulopathy in intensive care
por: Aron, J, et al.
Publicado: (2015) -
Screening of COVID-19-associated hypercoagulopathy using rotational thromboelastometry
por: Iwasaki, Yudai, et al.
Publicado: (2020) -
Chinese expert consensus on diagnosis and treatment of trauma-induced hypercoagulopathy
por: Song, Jing-Chun, et al.
Publicado: (2021) -
Inflammation and hypercoagulopathy are predominant risk factors of severity in COVID-19 patients with diabetes mellitus: Summary of a meta-analysis
por: Dhar, Sujan K., et al.
Publicado: (2021) -
Inflammasome Activation-Induced Hypercoagulopathy: Impact on Cardiovascular Dysfunction Triggered in COVID-19 Patients
por: Gedefaw, Lealem, et al.
Publicado: (2021)